robust top-line result support view pg organ
sale growth trajectori inflect drive
robust ep growth rel peer although
reinvestment/fx limit near-term upsid rel
remain ow net sum view post quarter understand
market disappoint weak profit flow believ call
sustain top-line inflect strengthen organ sale growth upsid
quarter well manag bullish tone industri top-line
outlook pg rel market share posit ultim sustain top-line
improv key driver stock view
top-line momentum weaker margin high bar head
ep pg stock fell vs robust organ sale
growth vs market expect rais organ sale
guidanc solid overshadow weaker expect profit
deliveri consensu less market optim top-line upsid
would flow ep upsid vs consensu given greater reinvest
specif pg expect provid fairli wide top bottom line
guidanc rang next quarter reflect dynam oper environ tougher
top-line comparison line headwind estim neg
ep impact lap like gillett land sale higher
tax rate understand increment concern particularli strong pg
stock price out-performance last quarter howev view
magnitud stock sell today bit overdon consid much
margin weak quarter due bp step market
drive forward growth well one-tim cost associ
merck transact abat time ii organ sale growth
momentum remain robust pg result strongest sinc
headlin strength beauti fabric
along broad base strength across pg portfolio confid tone
compani growth outlook pg construct hpc industri
environ given market growth inflect higher price realiz
improv evid pg result hpc industri broadli
household person unit state america
unless otherwis note metric base modelwar
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
quarter promot intens y-o-i basi particularli
us level drop percentag point vs prior year net
result give us greater convict call sustain organ top-line
growth re-rat rang year subpar deliveri
key driver ow thesi
price out-performance sinc ep octob vs hpc peer
continu see scope rel out-performance pg trade
price-to-earnings discount hpc peer cl/chd/clx/kmb despit superior
fundament growth outlook averag
tweak ep estim result tweak ep
estim cent ep estim fall
cent reduc margin expans outlook mostli
off-set lower tax rate pt remain unchang base
ep estim
number pg core ep consensu
mse top-line upsid robust organ sale growth slight
gm beat off-set greater expect sg larg
bp market increas drove profit miss vs consensu offset
profit miss lower tax rate flatter ep cent drive beat
quarter organ sale growth unround base mse came
well ahead consensu importantli market expect
rang two-year averag growth also acceler vs
price improv sequenti vs flat
y-o-i declin report top-line beat
boost slightli better expect gross margin bp
consensu gm flat y-o-i unfavor commod bp fx
bp product mix bp off-set cost save bp price
bp sg sale came larg bp consensu driven
market reinvest bp higher inflation/oth expens
bp fx bp off-set product save bp
sale leverag bp net oper profit beat consensu
om bp y-o-i
ep guidanc reiter rais organ sale guidanc pg rais
organ sale growth guidanc guid solid vs
prior all-in sale growth flat prior
includ fx headwind unchang net effect
acquisit divestitur modest posit impact all-in sale
growth unchang ep line compani reiter core ep
growth unchang base impli pg guidanc
midpoint in-lin prior consensu pg guidanc
includ billion unchang headwind foreign exchang
commod transport cost pg also rais adjust free cash flow
product guidanc least greater prior
expect pay billion dividend unchang repurchas
approxim billion common share vs billion prior
exhibit pg organ sale growth acceler
exhibit led improv categori growth moder market share
deriv base case scenario
top-line rebound organ sale growth revenu upsid bp int
upsid bp us upsid pg marketing/innov focu drive
market share improv cut forecast better
expect price realiz drive margin upsid turn ep growth
valuat expand ep
go forward hpc peer led improv us result
build market share momentum better price realiz continu cost
save support bp om expansion/yr drive hsd ep growth
appli multipl ep slight premium pg average given
us led topline/margin downsid us bear case scenario play
bp pricing/volum downsid along bp margin downsid greater
reinvest outsid us bp top-line downsid bp
margin downsid drive mute lsd ep growth valuat contract
year subpar organ top-line
growth believ strategi tweak put
place recent year begin bear
fruit acceler pg top-line growth
back rang
us improv breadth perform
confid market share momentum
sustain combin
improv price outlook greater agil
organiz chang implement
support top-line growth modestli hpc
nearli year gross margin declin
expect gm expans resum
led improv price realiz
combin sizabl cost save program
worth annual profit see scope
bp annual margin expans
turn hsd ep growth deliveri
valuat look compel rel
basi pg trade ep
discount hpc peer rel valuat
look compel consid call pg
fundament posit inflect year
under-perform vs expens hpc
risk achiev price
market share vacil currenc
exhibit bear bull top-line trend stock driver
valu
sale
sale
sale bp chang
sale
sale bp chang
prepaid expens current asset
note loan payabl
current portion long-term debt
accru liabil
reserv esop debt retir
depreci amort
chang a/l
a/p accru liabil
oper asset liabil
provid oper
flow invest activ
proce asset sale
payment acquisit
use invest activ
flow financ activit
chang short-term debt
chang long-term debt
purchas treasuri share
use financ activ
provid discontinu oper
exchang rate effect
net increas decreas
equiv beg
equiv end
